Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Kim

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 20, 2024
Evolving Standards of Care in the Management of Localized Colorectal CancerBenjamin A Weinberg, Paul E Sackstein, James Yu, et al.
Abdominal Radiology (New York)|March 17, 2025
Intrahepatic cholangiocarcinoma: role of imaging as a critical component for multi-disciplinary treatment approachBetzaira G Childers, Jason W Denbo, Richard D Kim, et al.
Cancer|December 8, 2020
Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancersElaine S Tan, Biwei Cao, Jongphil Kim, et al.
Bioinformatics (Oxford, England)|February 3, 2005
CrossChip: a system supporting comparative analysis of different generations of Affymetrix arraysSek Won Kong, Kyu-Baek Hwang, Richard D Kim, et al.
Clinical Nuclear Medicine|December 18, 2015
Metabolic Activity by 18F-FDG-PET/CT Is Prognostic for Stage I and II Pancreatic CancerJose M Pimiento, Ashley H Davis-Yadley, Richard D Kim, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 20, 2023
Radioembolization with Yttrium-90 Glass Microspheres as a First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma-A Prospective Feasibility StudyBela Kis, Ravi Shridhar, Rahul Mhaskar, et al.
Cancer|May 27, 2020
A multi-institutional phase 2 trial of regorafenib in refractory advanced biliary tract cancerRichard D Kim, Hanna K Sanoff, Andrew S Poklepovic, et al.
Cancers|February 10, 2024
Biomarker Analysis from a Phase I/Ib Study of Regorafenib and Nivolumab in Mismatch Repair-Proficient Advanced Refractory Colorectal CancerDae Won Kim, Young-Chul Kim, Bence P Kovari, et al.
Journal of Gastrointestinal Oncology|July 15, 2022
Anatomic patterns of recurrence in biliary tract cancers: does primary tumor site matter?Andrew J Sinnamon, Anthony C Wood, Megan A Satyadi, et al.
European Journal of Cancer (Oxford, England : 1990)|October 17, 2022
Biomarker analysis from a phase II multi-institutional study of nivolumab in patients with advanced refractory biliary tract cancerDae Won Kim, Young-Chul Kim, Bence P Kovari, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 20, 2024
Evolving Standards of Care in the Management of Localized Colorectal CancerBenjamin A Weinberg, Paul E Sackstein, James Yu, et al.
Abdominal Radiology (New York)|March 17, 2025
Intrahepatic cholangiocarcinoma: role of imaging as a critical component for multi-disciplinary treatment approachBetzaira G Childers, Jason W Denbo, Richard D Kim, et al.
Cancer|December 8, 2020
Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancersElaine S Tan, Biwei Cao, Jongphil Kim, et al.
Bioinformatics (Oxford, England)|February 3, 2005
CrossChip: a system supporting comparative analysis of different generations of Affymetrix arraysSek Won Kong, Kyu-Baek Hwang, Richard D Kim, et al.
Clinical Nuclear Medicine|December 18, 2015
Metabolic Activity by 18F-FDG-PET/CT Is Prognostic for Stage I and II Pancreatic CancerJose M Pimiento, Ashley H Davis-Yadley, Richard D Kim, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 20, 2023
Radioembolization with Yttrium-90 Glass Microspheres as a First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma-A Prospective Feasibility StudyBela Kis, Ravi Shridhar, Rahul Mhaskar, et al.
Cancer|May 27, 2020
A multi-institutional phase 2 trial of regorafenib in refractory advanced biliary tract cancerRichard D Kim, Hanna K Sanoff, Andrew S Poklepovic, et al.
Cancers|February 10, 2024
Biomarker Analysis from a Phase I/Ib Study of Regorafenib and Nivolumab in Mismatch Repair-Proficient Advanced Refractory Colorectal CancerDae Won Kim, Young-Chul Kim, Bence P Kovari, et al.
Journal of Gastrointestinal Oncology|July 15, 2022
Anatomic patterns of recurrence in biliary tract cancers: does primary tumor site matter?Andrew J Sinnamon, Anthony C Wood, Megan A Satyadi, et al.
European Journal of Cancer (Oxford, England : 1990)|October 17, 2022
Biomarker analysis from a phase II multi-institutional study of nivolumab in patients with advanced refractory biliary tract cancerDae Won Kim, Young-Chul Kim, Bence P Kovari, et al.
Pageof 6